Pfizer swings to wider-than-expected loss but keeps full-year outlook intact

Drugmaker looks to flurry of new products to drive growth as COVID sales drop.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.